Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Ancitabine

Ancitabine

Ancitabine structure

Ancitabine 

structure
  • CAS No:

    31698-14-3

  • Formula:

    C9H11N3O4

  • Chemical Name:

    Ancitabine

  • Synonyms:

    6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,(2R,3R,3aS,9aR)-;6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,[2R-(2α,3β,3aβ,9aβ)]-;6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,stereoisomer;6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-;(2R,3R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-6-imino-6H-furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol;O2,2′-Cyclocytidine;Cyclocytidine;2,2′-Anhydroarabinosylcytosine;2,2′-Anhydrocytidine;2,2′-O-Cyclocytidine;O2:2′-Anhydro-1-β-D-arabinosylcytosine;2,2′-Anhydro(1-β-D-arabinofuranosyl)cytosine;Ancytabine;2,2′-Cyclocytidine;Ancitabine;34939-46-3;36258-39-6;46488-37-3;51743-54-5

  • Categories:

    Active Pharmaceutical Ingredients  >  Antineoplastic Agents

Description

ChEBI: An organic heterotricyclic compound resulting from the formal condensation of the oxo group of cytidine to the 2' position with loss of water to give the corresponding cyclic ether. A prodrug, it is metabolised to the antineoplastic agent cytarabine, so is used to maintain a more constant antineoplastic action.


Ancitabine is an organic heterotricyclic compound resulting from the formal condensation of the oxo group of cytidine to the 2' position with loss of water to give the corresponding cyclic ether. A prodrug, it is metabolised to the antineoplastic agent cytarabine, so is used to maintain a more constant antineoplastic action. It has a role as a prodrug, an antimetabolite and an antineoplastic agent. It is an organic heterotricyclic compound and a diol. It is a conjugate base of an ancitabine(1+).|Ancitabine is a cytarabine congener prodrug with antineoplastic activity. Upon administration, ancitabine is slowly hydrolyzed into cytarabine, which is converted to the active triphosphate form and competes with deoxycytidine triphosphate for incorporation into DNA. Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle. This agent also inhibits DNA and RNA polymerases, resulting in a decrease in cell growth. Compared to cytarabine, a more prolonged, consistent cytarabine-mediated therapeutic effect may be achieved with ancitabine because of the slow hydrolytic conversion of ancitabine to cytarabine.|Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.

Ancitabine Basic Attributes

225.2

225.20

DO2D32W0VC

DTXSID6020357

C80636

Characteristics

98.4

-2.4

2.01 g/cm3

249 °C (decomp)

422.2ºCat 760 mmHg

1.5100 (estimate)

−20°C

Safety Information

2

LV2615000

Drug Information

Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)

Ancitabine

Computed Properties

Molecular Weight:225.20
XLogP3:-2.4
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:1
Exact Mass:225.07495584
Monoisotopic Mass:225.07495584
Topological Polar Surface Area:98.4
Heavy Atom Count:16
Complexity:394
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Ancitabine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.